Oarsman Capital’s Organon & Co OGN Stock Holding History

Oarsman Capital’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1	Closed	-$15	–	642
2024 Q4	$15	Hold	1	–	–	﹤0.01%	901
2024 Q3	$19	Buy	+1	New	+$21	﹤0.01%	906

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oarsman Capital's OGN Position: Q1 2025 in Review

Oarsman Capital sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 1 share — an estimated $15 sold.

Oarsman Capital first reported a position in OGN in Q3 2024 and held it in 2 quarters. The position peaked at $19 in Q3 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

Oarsman Capital reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 1 Organon & Co share in Q1 2025, an estimated $15.
Oarsman Capital first reported a position in Organon & Co in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Organon & Co position peaked at $19 in Q3 2024.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.